Variants with the N501Y mutation extend SARS-CoV-2 host range to mice, with contact transmission

Xavier Montagutelli, Matthieu Prot, Laurine Levillayer, +15

New VariantsViral PathogenesisImmunologyHost AdaptationCovid-19 +15

A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice

Claude Roth, Tineke Cantaert, Chloé Colas, +10

Frontiers in Immunology

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

Marion Plaze, David Attali, Matthieu Prot, +11

International Journal of Antimicrobial Agents

Human CellsMedicineImmunologyAntiviral Drug DevelopmentAntiviral Therapy +6

Rapid characterization of a Delta-Omicron SARS-CoV-2 recombinant detected in Europe

Etienne Simon‐Lorière, Xavier Montagutelli, Frédéric Lemoine, +49

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters

Phanramphoei Frantz, Aleksandr Barinov, Claude Ruffié, +21

Nature Communications

SARS-CoV-2 Induces Cytokine Responses in Human Basophils

Srinivasa Reddy Bonam, Camille Chauvin, Laurine Levillayer, +3

Frontiers in Immunology

InflammationCytokineKey RoleHuman BasophilsViral Immunity +9

Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine

Marion Plaze, David Attali, Matthieu Prot, +10

Cpz DosageMedicineHuman CellsImmunologyAntiviral Drug Development +10

A mouse-adapted SARS-CoV-2 strain replicating in standard laboratory mice

Xavier Montagutelli, Matthieu Prot, Grégory Jouvion, +8

Viral EvolutionInflammatory Lung DiseaseVirus Spike ProteinLung InflammationEmerging Infectious Diseases +13